Use of tolnaftate to treat herpes labialis

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3127

Patent

active

044381344

ABSTRACT:
Warm-blooded animals are treated for Herpes Simplex Virus-I by administering to the animal a dosage, effective to alleviate the symptoms of the virus, of Tolnaftate (chemically called 0-2-naphthyl-m,N-dimethylthio carbanilate) and at least one pharmaceutically acceptable carrier, wherein the compound is in the range of from about 0.01 to about 95% by weight of the composition.

REFERENCES:
Chemical Abstracts 88: 158482k (1978).
The Merck Index 9th Ed., 1976, Merck & Co., Inc., Rahway, N.J., p. 1224.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of tolnaftate to treat herpes labialis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tolnaftate to treat herpes labialis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tolnaftate to treat herpes labialis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1604041

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.